Teladoc Health Inc Stock Price, News & Analysis

Teladoc Health (TDOC) announced a milestone of surpassing 50 million visits delivered through its global network of clinicians. This achievement highlights the company's significant impact on health access over its 20-year history. Key growth metrics include a 4x increase in primary care visits year-to-date and a 30% rise in nutrition consultations. Additionally, 34% of patients in chronic condition management are utilizing multiple programs. The company has gained recognition in 2022, being named among America's Most Trusted Companies by Newsweek.

Teladoc Health reported a 17% year-over-year revenue increase to $611.4 million for Q3 2022 and a net loss of $73.5 million or $0.45 per share. Adjusted EBITDA fell 24% to $51.2 million. The company's cash flow from operations for the quarter was $63.0 million. U.S. revenues grew 17% while international revenues matched this growth. Despite the revenue growth, stock-based compensation and amortization charges contributed heavily to the net loss. For Q4, Teladoc expects revenue of $625 - $640 million.

Teladoc Health (NYSE: TDOC) has appointed Laizer Kornwasser as President of Enterprise Growth and Global Markets, effective October 24, 2022. Kornwasser will focus on enhancing revenue and profit from the company's whole-person care strategy across various client channels, including US Group Health and BetterHelp. With over 20 years in healthcare, he previously led CareCentrix and held positions at Medco. CEO Jason Gorevic highlighted Kornwasser's expertise in driving growth and managing teams as vital for strengthening Teladoc's market position.

Teladoc Health (NYSE: TDOC) will announce its third quarter 2022 financial results on October 26, 2022, after market close. A conference call will follow at 4:30 p.m. E.T. where executives will discuss the results. The call can be accessed by U.S. participants at 1-844-200-6205 or internationally at 1-929-526-1599, using access code #270257. A live audio webcast will also be available. Teladoc Health is known for its innovative virtual care solutions aimed at improving health outcomes.

Teladoc Health (TDOC) is offering free, 24/7 telehealth services to Florida residents affected by Hurricane Ian. Those displaced can access care for non-emergency conditions by calling 855-225-5032. Dr. Vidya Raman-Tangella emphasized the importance of prioritizing health during such crises. This initiative is part of Teladoc's long-standing commitment to provide virtual care during federally declared disasters. Over the past five years, the company has responded to various natural disasters, ensuring community access to healthcare services and necessary prescriptions.

Teladoc Health (NYSE: TDOC) announced free 24/7 telehealth visits for Florida residents impacted by Hurricane Ian. Those displaced can access licensed healthcare professionals for non-emergency illnesses by calling 855-225-5032. Chief Medical Officer Dr. Vidya Raman-Tangella emphasized the importance of health during such disasters, noting that virtual care is crucial for community wellbeing. Teladoc has a history of providing disaster support, aiding thousands during various natural emergencies across the U.S., ensuring access to necessary care and prescriptions.

Teladoc Health (TDOC) has launched an at-home A1C testing program as part of its Livongo chronic care solution, enabling members to better manage diabetes. The service, provided by LetsGetChecked, allows for convenient self-testing and aims to close care gaps. Notably, 58% of members opted for the service, which boasts a significantly higher return rate than alternatives. Furthermore, 87% of users reported controlled A1C levels under 8%, compared to a 54% average in commercial health plans. This initiative enhances access to care and improves health outcomes, aligning with Teladoc's commitment to whole-person health.

Teladoc Health (NYSE: TDOC) is offering free, 24/7 telehealth visits to residents and first responders in Kentucky affected by severe storms and flooding. The service allows individuals to seek treatment for non-emergency illnesses by calling Teladoc directly. This initiative aims to maintain community health during challenging times when local healthcare services may be disrupted. Teladoc has previously provided similar services during natural disasters, supporting numerous communities across the U.S. in 2021.

Teladoc Health reported an 18% revenue increase in Q2 2022, totaling $592.4 million, driven by a 20% rise in access fees. However, the company faced a significant net loss of $3.1 billion, primarily due to a non-cash goodwill impairment charge of $3 billion. Adjusted EBITDA decreased by 30% year-over-year to $46.7 million. U.S. revenues grew 18%, while international revenues rose 13%. For Q3 2022, the company expects revenues between $600 million and $620 million, with a projected net loss per share of $0.85 to $0.60.